Dr. Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). He completed his certification in Family Medicine in 1994 (also at University of Toronto). After completion of his family medicine training, he immediately joined a palliative home care team at his local hospital. This is how his focus on cancer patients began.
In 1999, Dr. Khan co-founded P.A.L.I.N., a registered charitable corporation which addressed the growing needs of cancer patients requiring at-home symptom control and enhanced quality of life.
In 2006, Dr. Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr. Khan gained international recognition and has been treating patients from all over the world. He is privileged to be the first doctor in the world to prescribe offlabel dichloroacetate (DCA) to treat cancer with positive results. As a result, he now has the most DCA experience of any physician in the world with over 1400 cancer patients treated as of October 2013. He is also the first in the world to demonstrate the curative potential of DCA when used as an adjuvant to chemotherapy or radiotherapy (one case published, second publication pending).
Dr. Khan is regularly publishing ground-breaking cancer papers in peer-reviewed medical journals such as:
“Individualizing Chemotherapy using the Anti-Diabetic Drug, Metformin, an Adjuvant: An Exploratory Study”, Bradford, S, Khan A, J Cancer Sci Ther 2013, 5.3
“Case Report of Long Term Complete Remission of Metastatic Renal Squamous Cell Carcinoma After Palliative Radiotherapy and Adjuvant Dichloroacetate”, Khan A, Advances in Cancer Research and Treatment, Vol 2012 (2012) [Epub]
“Use of Oral Dichloroacetate for Palliation of Leg Pain Arising from Metastatic Poorly Differentiated Carcinoma: A Case Report.” Khan A, J Palliat Med. 2011 Apr 12. [Epub ahead of print]
Dr. Khan is actively involved in undergraduate and post-graduate teaching and has been regularly invited to present lectures on various topics in palliative medicine and cancer therapy since 2000.